Current news and developments from the IMP. For frequent updates, also consider following us on our social media channels, such as Twitter ("X") or LinkedIn.
Sven Klumpe, joint Group Leader at the IMP and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), has received a new...
Plasma cells are the immune system’s antibody factories, but how B cells make the switch to become plasma cells has remained unclear. By developing a...
To keep cells running, ribosomes—the molecular machines that make proteins—must be built continuously and with high precision. Now, researchers from...
Two protein complexes that regulate intracellular transport and lysosome positioning were long thought to exist as single, well-defined entities. New...
Our B-cells use somatic hypermutation to fine-tune their DNA code to make better antibodies — but not all DNA sites are treated equally. A new study...